Latest News and Press Releases

Austin, TX, USA, June 17, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “GLP-1 Receptor Agonist Market Size, Trends and Insights By Product Type...

Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for...

CleveMed has joined Beacon Biosignals to advance what is possible in at-home sleep diagnostics.

Enterprises lose over $2T annually due to inefficiencies in transaction settlements. Rivvun AI aims to bridge this gap.

Ona Therapeutics closes oversubscribed $86.6M Series B financing to advance first-in-class ADCs into clinical development for treatment-resistant cancers

TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- GLP North, a Canadian supplier focused on ready-to-use research pen formats, has added Retaject availability to its Canadian research catalogue. The...

BGB Group becomes BGBx, bringing consulting and communications together to help life science clients navigate complexity and deliver breakthrough results.

Therini Bio doses first patients in Ph1b trial evaluating novel anti-inflammatory therapy, THN391, in DME, and advances fibrin/VEGF bispecific THN622

Grand Cayman, May 26, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...

ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its...